ArticleWomen's health reports (New Rochelle, N.Y.)2025
Global Burden of Schizophrenia Among Women of Reproductive Age from 1990 to 2021: Trends, Inequalities, and Projections to 2040.
Article in Women's health reports (New Rochelle, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Schizophrenia poses a significant health challenge for women of reproductive age globally. This study aimed to analyze the global burden of schizophrenia among this population from 1990 to 2021 and project trends to 2040. Methods: We utilized data from the Global Burden of Disease Study 2021 to examine the incidence, prevalence, and disability-adjusted life years (DALYs) of schizophrenia among women aged 15-49 years. We analyzed trends across Sociodemographic Index (SDI) regions, performed decomposition analysis, assessed health inequalities, and projected future burdens. Results: From 1990 to 2021, global incidence cases increased by 35.68% to 513,255, while age-standardized incidence rates slightly decreased by 1.00%. Prevalence cases rose by 55.82% to 7,541,989. Low SDI regions experienced the highest percentage increases in burden. Decomposition analysis revealed population growth as the primary driver of increased burden globally (85.4% for DALYs), with varying patterns across SDI regions. Health inequality analysis showed a growing concentration of prevalence and DALYs in higher SDI regions. Projections indicate continued global increases in absolute burden through 2040, with decreasing age-standardized rates. Conclusions: The burden of schizophrenia among women of reproductive age has increased substantially, driven primarily by population growth, with significant disparities across SDI regions. Tailored interventions addressing region-specific drivers are needed to mitigate the growing impact of schizophrenia on this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.